Log in Create free account

The wire · Browse by subject

All releases →

// Drill Results Assays, intercepts & discoveries 967 // Resource & Studies Estimates, PEAs & feasibility 373 // M&A & Deals Acquisitions, JVs & earn-ins 561 // Financing Placements, bought deals, flow-through 800 // Production & Operations Pours, throughput & guidance 443 // Permitting & ESG Approvals, permits & policy 276 // Corporate Boards, listings & results 1,276 // General Everything else on the wire 193

The Dispatch · Free

Every release, graded before the open.

4,889 releases read & graded
8 subjects, classified
Today's read, when you want it

Latest · Jun 26, 2026

Read today's edition →

Go deeper than the wire

Stories Features, explainers & analysis across the sector Guides Company & sector deep dives, built to be referenced Floor guides Who to see on the show floor at the big events Events Conferences, training & webinars across the sector

On the calendar

Conferences, expos & show floors.

Where the sector gathers, and who's exhibiting. Browse upcoming events across mining and energy.

See events →

Commodities

Gold 650 Copper 353 Silver 220 Lithium 107 Nickel 84 Zinc 83 Uranium 50 Platinum/PGM 38

Regions

Canada 504 Latin America 264 USA 231 BC 164 ON 145 QC 128 NV 107 Mexico 88

Combine topics

Stack a commodity and a place.

Pair a commodity with a region for a focused view — like Uranium + Saskatchewan or Lithium + Québec.

All topics →

V

Voyageur Pharmaceuticals Ltd.

TSXV:VM

Press release

Voyageur Pharmaceuticals Engages Fluor To Advance Feasibility Studies For Iodine Production And Integrated Contrast Drug Manufacturing Facility

Jun 23, 2026· Resource & Studies · indexed 3 days ago

Taking you to voyageurpharmaceuticals.ca in s… — paused. — off you go!

Continue to the release now →

Canadian Mining & Energy links to the original source — releases are never mirrored